Touyun Biotech Group Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was HKD 88.07 million compared to HKD 61.37 million a year ago. Basic loss per share from continuing operations was HKD 0.0314 compared to HKD 0.022 a year ago.